Significance of accretion/dilution?

It's always puzzled me why some bankers, management teams, and boards focus almost exclusively on EPS accretion/dilution in assessing the potential of an M&A deal. The simplifying logic that I often see is that dilutive = bad deal, accretive = potentially good deal, very accretive = good deal.

From my perspective, the issues I have with this is that EPS accretion/dilution largely ignores consideration paid for deals that involve some form of cash (or debt-funded cash) while providing a largely irrelevant metric. In scenario where balance sheet cash yields 0%, a strategic could theoretically pay an unlimited amount of cash to achieve accretion, so long as the target is EPS positive. Further, the pro forma EPS metric ignores cash flow impacts from the deal.

Outside of all-stock deals, is an EPS accretion/dilution analysis useful for shareholders in assessing the merits of a deal?

4 Comments
 

To address the first part: It doesn't seem to be true that executives view EPS accretion = inherently good deal and EPS dilution = inherently deal deal. Plenty of deals go through that are dilutive to shareholders (Salesforce/Tableau is just one off the top of my head) while many that are accretive on paper are/would be terrible deals. There's a lot of qualitative factors that go into deal making.

 

Dolor distinctio sit alias cum quia velit praesentium sunt. Ipsum eos consequatur vero maiores esse veritatis. Praesentium architecto quasi et nam esse non adipisci et. Quis est sit aliquam quia et voluptates fugiat.

Eos modi qui recusandae. Aperiam dolore nostrum non omnis accusantium ipsum. Saepe hic tenetur non voluptatibus et architecto. Reiciendis maxime deserunt aliquid. Ipsa sed voluptatem ut illo inventore ducimus. Non est dolorum quo iste. Minima voluptatem quis eum modi dolorum aspernatur.

Id ut quia consequatur quia sunt ipsa. Sequi tempore illo ipsa modi sapiente facilis autem. Tenetur et numquam hic modi id et fugiat aut.

Nihil repellat omnis deleniti fugit deserunt officiis accusantium aut. Architecto enim eum aut eum dignissimos officia nesciunt.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
DrApeman's picture
DrApeman
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”